Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anus Neoplasms × durvalumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 69 Lung Neoplasms 32 Carcinoma, Hepatocellular 31 Small Cell Lung Carcinoma 23 Cholangiocarcinoma 16 Urinary Bladder Neoplasms 15 Neoplasms 14 Breast Neoplasms 14 Squamous Cell Carcinoma of Head and Neck 12 Colorectal Neoplasms 12 Triple Negative Breast Neoplasms 11 Esophageal Neoplasms 8 Stomach Neoplasms 7 Pancreatic Neoplasms 7 Ovarian Neoplasms 7 Liver Neoplasms 7 Biliary Tract Neoplasms 7 Recurrence 6 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Melanoma 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Neoplasms by Site 5 Carcinoma, Renal Cell 5 Bile Duct Neoplasms 5 Adenocarcinoma 5 Uterine Cervical Neoplasms 4 Respiratory Tract Neoplasms 4 Mesothelioma, Malignant 4

Interventions

Fluorouracil 11 Cisplatin 6 Capecitabine 5 pembrolizumab 4 dehydroftorafur 4 Radiotherapy 4 Radiation 4 Mitomycin 4 Specimen Handling 3 Paclitaxel 3 Drug Therapy 3 Cetuximab 3 Carboplatin 3 Biopsy 3 Radiotherapy, Intensity-Modulated 2 Platinum 2 Nivolumab 2 Mitozytrex 2 Magnetic Resonance Spectroscopy 2 Fluorodeoxyglucose F18 2 1,2-diaminocyclohexaneplatinum II citrate 2 toripalimab 1 tislelizumab 1 regorafenib 1 fludarabine phosphate 1 fludarabine 1 enzalutamide 1 durvalumab 1 avelumab 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04230759 2024-09-19

RADIANCE

Goethe University

Phase 2 Active not recruiting

Gastrointestinal

Anus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡